Clinical trials show progress in migraine frequency, skin cancer prevention

-
2:10
Milwaukee finally hit 80 degrees for the first time in September...
-
5:34
CBS 58’s Theater Thursdays: ’A Big Bold Beautiful Adventure’...
-
4:37
Rustic Road Brewing brings Oktoberfest celebration to Kenosha...
-
0:37
Man shot by officer after dropping and reaching for gun during...
-
2:58
Family and friends mourn crash victims as 2 remain hospitalized;...
-
1:10
CBS 58’s One Good Thing: Mike Curkov and Lance Allan talk with...
-
0:55
Ascension Elmbrook aims to combat isolation with social meal...
-
0:53
Fans hope Marquette-Wisconsin matchup helps boost women’s sports...
-
2:18
‘We can’t control the city’: Family and football coach...
-
2:14
Milwaukee mother mourns son, 11, fatally shot near 68th and...
-
2:08
Driver fleeing traffic stop crashes into car at 35th and Vliet,...
-
2:31
Milwaukee leaders call on parents, community after several violent...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.